Medical gas library

Standards

How are medical devices regulated in Bahrain?

How are medical devices and their authorised representatives regulated in Bahrain?

Short answer

In Bahrain, the National Health Regulatory Authority (NHRA) controls the quality of medical devices under Resolution No. 48 of 2020, as amended by Resolution No. 69 of 2024; NHRA Circular 5 of 2025 states that, for devices meeting international quality and safety standards, registration and marketing licences now last three years instead of one, and is addressed to authorised representatives.

NHRA Circular No. 5 of 2025, dated 24 March 2025 and addressed to all authorised representatives of medical devices, announces amendments made by Resolution No. 69 of 2024 to Resolution No. 48 of 2020 on the quality control of medical devices and products. The circular says the amendments take effect from the date of its publication and that all authorised representatives are required to comply.

What the 2025 circular changes

  • Licence term: Article 10 now states that the registration and marketing licence for devices that meet international quality and safety standards is valid for three years instead of one, subject to payment of the fees.
  • New definition: Article 1 gains a definition of low-risk home-use medical devices, with digital thermometers and blood pressure monitors as examples.
  • Reference authorities: a new Article 7 bis recognises registration certificates from the regulators of Saudi Arabia (SFDA), the United States (FDA), Australia (TGA), Japan (PMDA), the United Kingdom (MHRA), Ireland (HPRA), Switzerland (Swissmedic), France (ANSM) and Germany (BfArM) as an alternative pathway to the standard registration requirements.
  • Withdrawal: Article 12, which lets the Authority withdraw or prohibit a device that may pose a risk to patients or users, adds that the costs of destruction or disposal are borne by the violator.

Limits of this page

This page reports one circular; it does not cover the full text of Resolution No. 48 of 2020, which was not read, and it is not regulatory advice. The NHRA home page lists the circular with the title "Resolution No. (48) of 2024"; the circular document itself says Resolution No. 48 of 2020 as amended by Resolution No. 69 of 2024, and this page follows the document. NHRA's later traceability programme is covered in What is the NHRA medical device traceability programme?.

More questions

How long is a device registration and marketing licence valid in Bahrain?

NHRA Circular 5 of 2025 says that, for devices meeting international quality and safety standards, the licence is valid for three years instead of one, subject to payment of the fees.

Sources

Ultra Controlo figures come from its technical datasheets. Third-party facts were read at the source on the date shown.

Reviewed: · Ultra Controlo engineering · Markdown version

Related